Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination

Parker, W.Phillis, S.Yeung, D.Hughes, T.Scott, H.Branford, S.2015-03-182015-03-182014Blood, 2014; 124(1):153-1550006-49711528-0020http://hdl.handle.net/2440/90033Letter to the editoren© 2014 by The American Society of HematologyFusion Proteins, bcr-ablPolymerase Chain ReactionMutationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveArtifactsMany BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombinationJournal article003001715510.1182/blood-2014-05-5734850003426183000232-s2.0-84903937403113988Yeung, D. [0000-0002-7558-9927]Hughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509]Scott, H. [0000-0002-5813-631X]Branford, S. [0000-0002-1964-3626] [0000-0002-5095-7981]